These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31282477)

  • 1. Crystal structures of the closed form of Mycobacterium tuberculosis dihydrofolate reductase in complex with dihydrofolate and antifolates.
    Ribeiro JA; Chavez-Pacheco SM; de Oliveira GS; Silva CDS; Giudice JHP; Libreros-Zúñiga GA; Dias MVB
    Acta Crystallogr D Struct Biol; 2019 Jul; 75(Pt 7):682-693. PubMed ID: 31282477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium tuberculosis dihydrofolate reductase reveals two conformational states and a possible low affinity mechanism to antifolate drugs.
    Dias MV; Tyrakis P; Domingues RR; Paes Leme AF; Blundell TL
    Structure; 2014 Jan; 22(1):94-103. PubMed ID: 24210757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of 5-deazapteridine derivatives with Mycobacterium tuberculosis and with human dihydrofolate reductases.
    da Cunha EF; de Castro Ramalho T; Bicca de Alencastro R; Maia ER
    J Biomol Struct Dyn; 2004 Oct; 22(2):119-30. PubMed ID: 15317473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using a Fragment-Based Approach to Identify Alternative Chemical Scaffolds Targeting Dihydrofolate Reductase from
    Ribeiro JA; Hammer A; Libreros-Zúñiga GA; Chavez-Pacheco SM; Tyrakis P; de Oliveira GS; Kirkman T; El Bakali J; Rocco SA; Sforça ML; Parise-Filho R; Coyne AG; Blundell TL; Abell C; Dias MVB
    ACS Infect Dis; 2020 Aug; 6(8):2192-2201. PubMed ID: 32603583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico structure-based design of a novel class of potent and selective small peptide inhibitor of Mycobacterium tuberculosis Dihydrofolate reductase, a potential target for anti-TB drug discovery.
    Kumar M; Vijayakrishnan R; Subba Rao G
    Mol Divers; 2010 Aug; 14(3):595-604. PubMed ID: 19697148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding mode analysis of 2,4-diamino-5-methyl-5-deaza-6-substituted pteridines with Mycobacterium tuberculosis and human dihydrofolate reductases.
    da Cunha EF; Ramalho TC; Reynolds RC
    J Biomol Struct Dyn; 2008 Feb; 25(4):377-85. PubMed ID: 18092832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isomorphous crystal structures of Escherichia coli dihydrofolate reductase complexed with folate, 5-deazafolate, and 5,10-dideazatetrahydrofolate: mechanistic implications.
    Reyes VM; Sawaya MR; Brown KA; Kraut J
    Biochemistry; 1995 Feb; 34(8):2710-23. PubMed ID: 7873554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of recombinant human dihydrofolate reductase complexed with folate and 5-deazafolate.
    Davies JF; Delcamp TJ; Prendergast NJ; Ashford VA; Freisheim JH; Kraut J
    Biochemistry; 1990 Oct; 29(40):9467-79. PubMed ID: 2248959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural studies on bioactive compounds. 30. Crystal structure and molecular modeling studies on the Pneumocystis carinii dihydrofolate reductase cofactor complex with TAB, a highly selective antifolate.
    Cody V; Chan D; Galitsky N; Rak D; Luft JR; Pangborn W; Queener SF; Laughton CA; Stevens MF
    Biochemistry; 2000 Apr; 39(13):3556-64. PubMed ID: 10736154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs.
    Li R; Sirawaraporn R; Chitnumsub P; Sirawaraporn W; Wooden J; Athappilly F; Turley S; Hol WG
    J Mol Biol; 2000 Jan; 295(2):307-23. PubMed ID: 10623528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.
    Senkovich O; Schormann N; Chattopadhyay D
    Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic dysfunction in dihydrofolate reductase results from antifolate drug binding: modulation of dynamics within a structural state.
    Mauldin RV; Carroll MJ; Lee AL
    Structure; 2009 Mar; 17(3):386-94. PubMed ID: 19278653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution structure of human dihydrofolate reductase in its complex with trimethoprim and NADPH.
    Kovalevskaya NV; Smurnyy YD; Polshakov VI; Birdsall B; Bradbury AF; Frenkiel T; Feeney J
    J Biomol NMR; 2005 Sep; 33(1):69-72. PubMed ID: 16222560
    [No Abstract]   [Full Text] [Related]  

  • 14. Propargyl-Linked Antifolates Are Potent Inhibitors of Drug-Sensitive and Drug-Resistant Mycobacterium tuberculosis.
    Hajian B; Scocchera E; Keshipeddy S; G-Dayanandan N; Shoen C; Krucinska J; Reeve S; Cynamon M; Anderson AC; Wright DL
    PLoS One; 2016; 11(8):e0161740. PubMed ID: 27580226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Insights into Mycobacterium tuberculosis Rv2671 Protein as a Dihydrofolate Reductase Functional Analogue Contributing to para-Aminosalicylic Acid Resistance.
    Cheng YS; Sacchettini JC
    Biochemistry; 2016 Feb; 55(7):1107-19. PubMed ID: 26848874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-induced conformational changes in the crystal structures of Pneumocystis carinii dihydrofolate reductase complexes with folate and NADP+.
    Cody V; Galitsky N; Rak D; Luft JR; Pangborn W; Queener SF
    Biochemistry; 1999 Apr; 38(14):4303-12. PubMed ID: 10194348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-pressure protein crystal structure analysis of Escherichia coli dihydrofolate reductase complexed with folate and NADP
    Nagae T; Yamada H; Watanabe N
    Acta Crystallogr D Struct Biol; 2018 Sep; 74(Pt 9):895-905. PubMed ID: 30198899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structures of Klebsiella pneumoniae dihydrofolate reductase bound to propargyl-linked antifolates reveal features for potency and selectivity.
    Lamb KM; Lombardo MN; Alverson J; Priestley ND; Wright DL; Anderson AC
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7484-91. PubMed ID: 25288083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-guided functional studies of plasmid-encoded dihydrofolate reductases reveal a common mechanism of trimethoprim resistance in Gram-negative pathogens.
    Krucinska J; Lombardo MN; Erlandsen H; Estrada A; Si D; Viswanathan K; Wright DL
    Commun Biol; 2022 May; 5(1):459. PubMed ID: 35562546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium tuberculosis dihydrofolate reductase is a target for isoniazid.
    Argyrou A; Vetting MW; Aladegbami B; Blanchard JS
    Nat Struct Mol Biol; 2006 May; 13(5):408-13. PubMed ID: 16648861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.